Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Verastem

May 2026

Verastem Market Share Analysis for May 2026

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Year Founded2010
Employees51 - 200
Annual Revenue$25M - $50M
verastem.com
Verastem
Verastem (including company regionals)
  • verastem.com
    verastem.com
See more website traffic and engagement information

Verastem Revenue up to May 2026 is 25M - 50M

revenue generated by Verastem top domains

Verastem top domains revenue over 3 years

Revenue for Verastem top domains


Total visits to Verastem's top domains

Understand Verastem market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Verastem's top domains

Analyze Verastem engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Verastem's top domains

See how Verastem keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Verastem

These are the website technologies, by industry, used by Verastem top domains

Advertising (6)

DoubleClick

DoubleClick

Widget (5)

Twemoji

Twemoji

Audio Video Media (4)

YouTube

YouTube

Conversion & Analytics (3)

Google Analytics

Google Analytics

More Technologies

10

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Verastem

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVerastem, Inc. is developing RAF/MEK inhibitors and PI3K pathway therapies targeting solid tumor cancers on Jun 24th '26.- Verastem is developing RAF/MEK inhibitors and PI3K pathway therapies targeting solid tumor cancers.
NewsVerastem, Inc. launched AVMAPKI FAKZYNJA CO-PACK therapy on May 1st '26.The appointment comes during a transition period for Verastem as the company balances commercial execution for its recently launched AVMAPKI FAKZYNJA CO-PACK therapy with continued development of VS-7375, its oral KRAS G12D inhibitor candidate.
NewsVerastem, Inc. hired Michael P. Bailey as Board of Directors on May 26th '26.Verastem Oncology appoints Michael P. Bailey to its Board of Directors.

See all Verastem signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.